Financial Advocates Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,572
Closed -$270K 752
2024
Q3
$270K Sell
1,572
-18
-1% -$3.1K 0.02% 632
2024
Q2
$245K Sell
1,590
-1,355
-46% -$209K 0.02% 621
2024
Q1
$453K Sell
2,945
-225
-7% -$34.6K 0.03% 476
2023
Q4
$501K Buy
3,170
+29
+0.9% +$4.58K 0.03% 428
2023
Q3
$460K Sell
3,141
-127
-4% -$18.6K 0.03% 430
2023
Q2
$500K Buy
3,268
+425
+15% +$65.1K 0.04% 408
2023
Q1
$441K Buy
2,843
+267
+10% +$41.4K 0.03% 448
2022
Q4
$397K Buy
2,576
+28
+1% +$4.32K 0.03% 490
2022
Q3
$336K Sell
2,548
-316
-11% -$41.7K 0.03% 508
2022
Q2
$388K Sell
2,864
-850
-23% -$115K 0.03% 447
2022
Q1
$554K Sell
3,714
-1,856
-33% -$277K 0.04% 414
2021
Q4
$902K Sell
5,570
-991
-15% -$160K 0.06% 338
2021
Q3
$1.09M Sell
6,561
-394
-6% -$65.5K 0.07% 291
2021
Q2
$1.2M Sell
6,955
-637
-8% -$110K 0.08% 282
2021
Q1
$1.22M Sell
7,592
-286
-4% -$45.9K 0.09% 265
2020
Q4
$1.29M Buy
7,878
+3,874
+97% +$635K 0.09% 256
2020
Q3
$630K Sell
4,004
-26
-0.6% -$4.09K 0.05% 325
2020
Q2
$676K Buy
4,030
+315
+8% +$52.8K 0.06% 296
2020
Q1
$487K Hold
3,715
0.07% 278
2019
Q4
$553K Sell
3,715
-517
-12% -$77K 0.06% 292
2019
Q3
$524K Sell
4,232
-7,560
-64% -$936K 0.06% 275
2019
Q2
$1.66M Buy
11,792
+670
+6% +$94.3K 0.19% 130
2019
Q1
$1.68M Buy
11,122
+478
+4% +$72.1K 0.21% 122
2018
Q4
$1.32M Sell
10,644
-178
-2% -$22.1K 0.18% 137
2018
Q3
$1.72M Buy
10,822
+6,675
+161% +$1.06M 0.19% 127
2018
Q2
$587K Buy
4,147
+313
+8% +$44.3K 0.07% 248
2018
Q1
$510K Sell
3,834
-47
-1% -$6.25K 0.07% 254
2017
Q4
$483K Buy
+3,881
New +$483K 0.07% 260